Hurry there is still time to register for the APSAD Conference! 
View this email in your browser
Forward to Friend
The Countdown has started with two weeks to go until the conference kicks off! 

Missed the online registration deadline? No need to sit there nursing your FOMO!
if you hurry, there is still time to register...

You won't want to miss out on the engaging program represented by our 9 keynotes, 2 invited speakers, symposia, poster presentations, workshops, late breakers and the peer-reviewed abstract-driven sessions running over three days in the picturesque Auckland surrounded by beautiful harbours. 

To register please use this link. If you have any questions regarding registration please contact the conference secretariat. 
Register Now

You are able to download and install the mobile app from your Android or Apple App Stores. 
  • iPhones and iPads, click here to access The Events App by EventsAIR in the Apple App Store
  • Android devices, click here to access The Events App by EventsAIR in the Google Play Store
Alternatively, you can search for "EventsAIR" to find The Events App by EventsAIR in your respective App Store.
Once you have found the app in your App Store: 
1.    Install the App.
2.    Enter the event code: apsad2018
3.    Keep an eye out for an email from the conference secretariat providing you with your unique login details to create your user account. 
Keynote Highlights
APSAD Early Career Award Winner & Keynote Associate Professor Gillian Gould

Associate Professor Gillian Gould’s focus to improve tobacco smoking risks for Indigenous Australians. She co-developed, over a decade, strategies to tackle smoking with Aboriginal communities, and led a regional Indigenous Tobacco Control Initiative (2010-12).
Gould is an NHMRC Early Career Research Fellow and a Cancer Institute NSW ECR Fellow, at University of Newcastle (UON). The fellowships will improve strategies for pregnant Indigenous smokers. Gould is co-founder of the Coffs Harbour Refugee Clinic, a practising GP and a Tobacco Treatment Specialist, with a wealth of clinical experience assisting smokers to quit. She has an MBChB (University of Leeds) and MA (Arts Therapy). 
Gould was awarded a career total of $6.6M in funding ($5.5M in last 3 years) and has 107 publications (35 journal articles), majority since 2012. Her contribution to Indigenous research is recognised by multiple awards: National Lead Clinicians Excellence Award for Indigenous Cultural Competence (2014), RACGP Indigenous Health Awards (2008, 2014) and Faculty of Aboriginal & Torres Strait Islander Health ‘Standing Strong Together Award’ (2009),
Alan Chancellor Award (2016), Hunter Children’s Research Foundation Excellence Award (2016), HMRI ECR award (2017), Cure Cancer Australia Researcher of the Year (runner up 2018). She was awarded International Visiting Research Fellowships to visit the Mayo Clinic, USA in 2017, and in 2018 to visit Maori colleagues in New Zealand. Gould is on two working parties for the Global Alliance for Chronic Disease. Gould supervises 6 high-caliber PhD students at UON, and leads a multi-disciplinary team for the national SISTAQUIT (Supporting Indigenous Smokers To Assist Quitting) research project.

The presentation title: Smoking in pregnancy – why it matters and how can we help?

Keynote Dr Sandra Comer is Professor of Neurobiology in the Department of Psychiatry at Columbia University. She received her BS at Vanderbilt University and PhD at the University of Michigan for her research on the effects of abused drugs using preclinical models. 

Dr Comer’s current research focus is on the clinical testing of medications for treating opioid use disorder, methods to maximize the use of naloxone by opioid users, and evaluations of the comparative abuse liability of prescribed pain medications. 

Dr Comer recently served as President of the College on Problems of Drug Dependence, the longest standing scholarly society in the U.S. devoted to research on substance use disorders, and currently is the Public Policy Officer for CPDD so she regularly meets with legislative offices on Capitol Hill. Dr Comer recently joined the Expert Advisory Panel on Drug Dependence for the WHO and has over 140 publications on substance use disorders.

Presentation tile: Fentanyl: Rise in Illicit Use and Implications for Treatment

Keynote Elizabeth Elliott AM is Professor in Paediatrics and Child Health at the University of Sydney and Consultant Paediatrician at the Children’s Hospital at Westmead. Throughout her career she has been dedicated to improving health and quality of life for children in Australia and beyond, through education, research, clinical care and advocacy.

During 30 years she has established an international reputation for high quality laboratory, clinical and public health research and holds a prestigious senior National Health and Medical Research Council (NHMRC) Practitioner Fellowship.

In 1993 she founded a national research resource, the Australian Paediatric Surveillance Unit (APSU), to facilitate study of rare childhood diseases, and is its Director. She helped establish and co-leads the Paediatric Active Enhanced Disease Surveillance (PAEDS) system for inpatient disease surveillance, which was invaluable in monitoring pandemic influenza in 2009 pandemic. This project was named one of the ’10 of the Best’ of thousands of NHMRC funded projects for 2013.

Elizabeth is an advocate for children, particularly disadvantaged children with rare diseases, fetal alcohol spectrum disorders and female genital mutilation; Indigenous children, and children in immigration detention. She consulted to the Australian Human Rights Commission in 2014 for the Inquiry into Children in Immigration Detention.

The presentation title: Alcohol in Pregnancy and Fetal Alcohol Spectrum Disorder (FASD): Research to Policy and Practice

Keynote Dr Jane Buxton is a public health physician and professor in the School of Population and Public Health at the University of British Columbia, Canada.
She is the harm reduction lead at the BC Centre for Disease Control where she oversees the provincial distribution of harm reduction supplies and developed the Drug Overdose and Alert Partnership in 2011 - an intersectoral collaboration including enforcement, coroners, emergency health services, public health and people with lived experience of substance use.

Jane led the implementation of the provincial Take-Home-Naloxone program in 2012 - which in 2017 distributed 60,000 kits with 15,000 kits reported used to reverse an overdose.
Jane is also passionate about ensuring authentic engagement of people with lived experience (the experts) to develop policy; plan, implement and evaluate programs; and in research. She uses quantitative and qualitative approaches in her work and is involved with the BC opioid overdose crisis response.

The presentation title: What can we learn from the overdose crisis?
Poster Session

The annual poster session continues to showcase high-quality submissions and this year's conference is no exception. We have 86 high-quality posters representing the broad spectrum of interests from across the sector. 

The Poster Session offers a great platform to connect and communicate, to discuss projects, ideas and developments face-to-face with all conference delegates. Be sure to make a note of your favourite poster and fill in your voting slip for the People's Choice Poster Award!

With 86 posters to view why not get in early and start planning all the posters you must see.
Here is the link listing all the posters along with the abstracts. 
2018 Poster Program

Mon 5 Nov 10.25 - 10.40
Poster Highlights Session One  

Tues 6 Nov 13.50 - 14.00 
Poster Highlights Session Two  

Tues 6 Nov 14.50 - 15.50 
Poster Session/Exhibition    

Wed 7 Nov 15.20
Poster Awards Presentation


Poster List
CLINICAL SITE VISIT PROGRAM - last chance to register

Be quick we still have a few spots remaining for this excellent tour! 
APSAD Conference has organised a site visit to two key AOD services in Auckland. A bus will pick delegates up from the Pullman Hotel and will take you to both services and return you to the hotel.​

Community Alcohol and Drug Service (CADS) Auckland is a large community-based alcohol and drug provider that engages around 15,000 people per annum in the Auckland region.

Higher Ground is a 50 bed Therapeutic Community also based in Auckland.

For full details of this tour visit our website
Book Now
Thanks to our sponsors and supporters 
Platinum Sponsor                                                      
Gold Sponsor 
Silver Sponsor 

Silver Sponsor 
         Travel Scholarship Sponsor  
Copyright © 2018 APSAD Conference, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

Email Marketing Powered by Mailchimp